The bursts in the LGN appear crucial for recovery, as mice genetically modified to prevent these bursts did not show improvement, indicating the mechanism relies on this early synchronized activity.

The technique has only been tested in animals so far; researchers caution that it remains to be studied for safety and effectiveness in humans, noting that similar burst-triggering effects have been observed when the non-amblyopic eye is temporarily anesthetized.

Scientists envision that noninvasive brain-stimulation approaches might eventually replicate these bursts without injections, offering a potential future therapy for amblyopia in both adults and children.

MIT and prior work showed that inactivating the non-amblyopic eye can also promote recovery, suggesting that re-creating early visual system activity patterns may drive the plasticity needed to treat amblyopia.

Researchers report that temporarily shutting down the weaker eye in mice using the local anesthetic tetrodotoxin can trigger synchronized bursts in the LGN, offering a potential path to reversing amblyopia even after long-standing vision issues.

The study emphasizes that findings are preliminary and limited to animal models, underscoring the need for further research to evaluate safety, efficacy, and practical application in humans.

In a mouse study published in Cell Reports, inactivating the amblyopic eye led to more balanced input to the visual cortex from both eyes a week later, suggesting the weak eye could catch up once activity patterns are reactivated.